Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.
about
Effects of repeated treatment with phosphodiesterase-4 inhibitors on cAMP signaling, hippocampal cell proliferation, and behavior in the forced-swim testDrug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repairThe phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recoveryThe antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis.Novel drugs and therapeutic targets for severe mood disorders.Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades.Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.Pharmacology of second messengers: a critical appraisal.Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.Differential phosphodiesterase expression and cytosolic Ca2+ in human CNS tumour cells and in non-malignant and malignant cells of rat origin.Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization.Cyclic AMP response element-binding protein and depression.The Past, Present, and Future of Phosphodiesterase-4 Modulation for Age-Induced Memory Loss.The PDE4 cAMP-Specific Phosphodiesterases: Targets for Drugs with Antidepressant and Memory-Enhancing Action.Effects of rolipram on the elevated plus-maze test in rats: a preliminary study.
P2860
Q23916644-9D7890BF-5990-48A3-918D-8D2D030959B8Q30541073-93015ECA-1E2D-4EFC-A475-9ED5AB8F751FQ34515590-11AB3BBA-FE1F-469D-B62B-4DA880368E92Q34720182-BDAEF662-CDD0-47F9-9485-77103CA3E1A3Q34732759-61F960A8-23A4-4D01-83EC-7F1923201ADDQ35006705-7EE47014-EA7F-4443-88CC-91B9489E6BE8Q35770190-5EB907FB-599E-4CB2-9D5A-9DDE878CF46CQ36071589-1D37602F-6E14-42B5-8500-8796D9F9ECBCQ37388604-E7C9A5DA-EFB6-412B-B2E0-8FD24558E2C5Q40437564-D14D8D34-AFD6-4C4A-91F8-C8752A5EF0BAQ42523866-306EB7C8-D802-41D0-B8FE-3A8F81371466Q43265627-2711086C-AFC5-4279-9BA2-C1A0D3D96B57Q45068631-4CDB9DD9-40E6-468E-9BFE-3B7D7A7A3F20Q47732733-7DED5E04-8190-45AE-B01D-FB946C2CD378Q51085423-8E937236-71C1-4347-BE7B-78A423D52529
P2860
Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Rolipram, a novel antidepressa ...... tsynaptic monoamine receptors.
@en
Rolipram, a novel antidepressa ...... tsynaptic monoamine receptors.
@nl
type
label
Rolipram, a novel antidepressa ...... tsynaptic monoamine receptors.
@en
Rolipram, a novel antidepressa ...... tsynaptic monoamine receptors.
@nl
prefLabel
Rolipram, a novel antidepressa ...... tsynaptic monoamine receptors.
@en
Rolipram, a novel antidepressa ...... tsynaptic monoamine receptors.
@nl
P1433
P1476
Rolipram, a novel antidepressa ...... tsynaptic monoamine receptors.
@en
P2093
Schneider HH
P304
P356
10.1016/0028-3908(86)90159-0
P577
1986-10-01T00:00:00Z